{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:22:53Z","timestamp":1792790573292,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI117519"],"award-info":[{"award-number":["R21AI117519"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI132599"],"award-info":[{"award-number":["R01AI132599"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"crossref"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","id":[{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We evaluate gene editing of HSV in a well-established mouse model, using adeno-associated virus (AAV)-delivered meganucleases, as a potentially curative approach to treat latent HSV infection. Here we show that AAV-delivered meganucleases, but not CRISPR\/Cas9, mediate highly efficient gene editing of HSV, eliminating over 90% of latent virus from superior cervical ganglia. Single-cell RNA sequencing demonstrates that both HSV and individual AAV serotypes are non-randomly distributed among neuronal subsets in ganglia, implying that improved delivery to all neuronal subsets may lead to even more complete elimination of HSV. As predicted, delivery of meganucleases using a triple AAV serotype combination results in the greatest decrease in ganglionic HSV loads. The levels of HSV elimination observed in these studies, if translated to humans, would likely significantly reduce HSV reactivation, shedding, and lesions. Further optimization of meganuclease delivery and activity is likely possible, and may offer a pathway to a cure for HSV infection.<\/jats:p>","DOI":"10.1038\/s41467-020-17936-5","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T06:03:29Z","timestamp":1597730609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Gene editing and elimination of latent herpes simplex virus in vivo"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1125-6856","authenticated-orcid":false,"given":"Martine","family":"Aubert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Strongin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4567-8232","authenticated-orcid":false,"given":"Pavitra","family":"Roychoudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Loprieno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoria K.","family":"Haick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay M.","family":"Klouser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Stensland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meei-Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Makhsous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Tait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshana S.","family":"De Silva Feelixge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Galetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3491-9168","authenticated-orcid":false,"given":"Philippe","family":"Duchateau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander L.","family":"Greninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1619-7541","authenticated-orcid":false,"given":"Daniel","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8212-3789","authenticated-orcid":false,"given":"Keith R.","family":"Jerome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,18]]},"reference":[{"key":"17936_CR1","unstructured":"Fields, B., Knipe, D., Howley, P. & Griffin, D. Fields Virology (Wolters Kluwer Health\/Lippincott Williams & Wilkins, Philadelphia, 2007)."},{"key":"17936_CR2","first-page":"2244","volume":"43","author":"DE Bustos","year":"2002","unstructured":"Bustos, D. E. & Atherton, S. S. Detection of herpes simplex virus type 1 in human ciliary ganglia. Invest Ophthalmol. Vis. Sci. 43, 2244\u20132249 (2002).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"17936_CR3","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/BF00296546","volume":"82","author":"JR Martin","year":"1991","unstructured":"Martin, J. R., Jenkins, F. J. & Henken, D. B. Targets of herpes simplex virus type 1 infection in a mouse corneal model. Acta Neuropathol. 82, 353\u2013363 (1991).","journal-title":"Acta Neuropathol."},{"key":"17936_CR4","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1080\/jnv.9.6.594.602","volume":"9","author":"MB Parr","year":"2003","unstructured":"Parr, M. B. & Parr, E. L. Intravaginal administration of herpes simplex virus type 2 to mice leads to infection of several neural and extraneural sites. J. Neurovirol 9, 594\u2013602 (2003).","journal-title":"J. Neurovirol"},{"key":"17936_CR5","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1086\/648474","volume":"200","author":"ER Richter","year":"2009","unstructured":"Richter, E. R., Dias, J. K., Gilbert, J. E. 2nd & Atherton, S. S. Distribution of herpes simplex virus type 1 and varicella zoster virus in ganglia of the human head and neck. J. Infect. Dis. 200, 1901\u20131906 (2009).","journal-title":"J. Infect. Dis."},{"key":"17936_CR6","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/BF01314291","volume":"91","author":"NA Sanjuan","year":"1986","unstructured":"Sanjuan, N. A. & Lascano, E. F. Autonomic nervous system involvement in experimental genital infection by herpes simplex virus type 2. Arch. Virol. 91, 329\u2013339 (1986).","journal-title":"Arch. Virol."},{"key":"17936_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/BF01314229","volume":"85","author":"C Shimeld","year":"1985","unstructured":"Shimeld, C., Tullo, A. B., Hill, T. J., Blyth, W. A. & Easty, D. L. Spread of herpes simplex virus and distribution of latent infection after intraocular infection of the mouse. Arch. Virol. 85, 175\u2013187 (1985).","journal-title":"Arch. Virol."},{"key":"17936_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa035144","volume":"350","author":"L Corey","year":"2004","unstructured":"Corey, L. et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N. Engl. J. Med. 350, 11\u201320 (2004).","journal-title":"N. Engl. J. Med"},{"key":"17936_CR9","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1086\/424519","volume":"190","author":"R Gupta","year":"2004","unstructured":"Gupta, R. et al. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. J. Infect. Dis. 190, 1374\u20131381 (2004).","journal-title":"J. Infect. Dis."},{"key":"17936_CR10","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.4065\/81.10.1321","volume":"81","author":"KH Fife","year":"2006","unstructured":"Fife, K. H. et al. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial. Mayo Clin. Proc. 81, 1321\u20131327 (2006).","journal-title":"Mayo Clin. Proc."},{"key":"17936_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1001\/jama.1988.03410020067030","volume":"260","author":"GJ Mertz","year":"1988","unstructured":"Mertz, G. J. et al. Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial. JAMA 260, 201\u2013206 (1988).","journal-title":"JAMA"},{"key":"17936_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.7326\/0003-4819-124-1_Part_1-199601010-00002","volume":"124","author":"A Wald","year":"1996","unstructured":"Wald, A., Zeh, J., Barnum, G., Davis, L. G. & Corey, L. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann. Intern Med 124, 8\u201315 (1996).","journal-title":"Ann. Intern Med"},{"key":"17936_CR13","doi-asserted-by":"publisher","unstructured":"Aubert, M. et al. In vivo disruption of latent HSV by designer endonuclease therapy. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.88468 (2016).","DOI":"10.1172\/jci.insight.88468"},{"key":"17936_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.coviro.2016.09.012","volume":"20","author":"F Buchholz","year":"2016","unstructured":"Buchholz, F. & Hauber, J. Antiviral therapy of persistent viral infection using genome editing. Curr. Opin. Virol. 20, 85\u201391 (2016).","journal-title":"Curr. Opin. Virol."},{"key":"17936_CR15","doi-asserted-by":"publisher","unstructured":"Chen, Y. C., Sheng, J., Trang, P. & Liu, F. Potential application of the CRISPR\/Cas9 system against herpesvirus infections. Viruses https:\/\/doi.org\/10.3390\/v10060291 (2018).","DOI":"10.3390\/v10060291"},{"key":"17936_CR16","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1021\/acsinfecdis.7b00273","volume":"4","author":"HS De Silva Feelixge","year":"2018","unstructured":"De Silva Feelixge, H. S., Stone, D., Roychoudhury, P., Aubert, M. & Jerome, K. R. CRISPR\/Cas9 and genome editing for viral disease-is resistance futile? ACS Infect. Dis. 4, 871\u2013880 (2018).","journal-title":"ACS Infect. Dis."},{"key":"17936_CR17","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/mt.2010.302","volume":"19","author":"S Grosse","year":"2011","unstructured":"Grosse, S. et al. Meganuclease-mediated Inhibition of HSV1 infection in cultured cells. Mol. Ther. 19, 694\u2013702 (2011).","journal-title":"Mol. Ther."},{"key":"17936_CR18","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00439-016-1686-2","volume":"135","author":"D Stone","year":"2016","unstructured":"Stone, D., Niyonzima, N. & Jerome, K. R. Genome editing and the next generation of antiviral therapy. Hum. Genet. 135, 1071\u20131082 (2016).","journal-title":"Hum. Genet"},{"key":"17936_CR19","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1002\/jcb.26099","volume":"118","author":"MK White","year":"2017","unstructured":"White, M. K., Kaminski, R., Young, W. B., Roehm, P. C. & Khalili, K. CRISPR editing technology in biological and biomedical investigation. J. Cell Biochem 118, 3586\u20133594 (2017).","journal-title":"J. Cell Biochem"},{"key":"17936_CR20","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1038\/mtna.2013.75","volume":"3","author":"M Aubert","year":"2014","unstructured":"Aubert, M. et al. In vitro inactivation of latent HSV by targeted mutagenesis using an HSV-specific homing endonuclease. Mol. Ther. Nucleic Acids 3, e146 (2014).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"17936_CR21","doi-asserted-by":"publisher","first-page":"7784","DOI":"10.1128\/JVI.78.14.7784-7794.2004","volume":"78","author":"NM Sawtell","year":"2004","unstructured":"Sawtell, N. M. & Thompson, R. L. Comparison of herpes simplex virus reactivation in ganglia in vivo and in explants demonstrates quantitative and qualitative differences. J. Virol. 78, 7784\u20137794 (2004).","journal-title":"J. Virol."},{"key":"17936_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01004-y","volume":"7","author":"CH Dang","year":"2017","unstructured":"Dang, C. H. et al. In vivo dynamics of AAV-mediated gene delivery to sensory neurons of the trigeminal ganglia. Sci. Rep. 7, 927 (2017).","journal-title":"Sci. Rep."},{"key":"17936_CR23","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1016\/j.celrep.2016.11.057","volume":"17","author":"G Wang","year":"2016","unstructured":"Wang, G., Zhao, N., Berkhout, B. & Das, A. T. A combinatorial CRISPR-Cas9 attack on HIV-1 DNA extinguishes all infectious provirus in infected T cell cultures. Cell Rep. 17, 2819\u20132826 (2016).","journal-title":"Cell Rep."},{"key":"17936_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/srep41968","volume":"7","author":"RJ Lebbink","year":"2017","unstructured":"Lebbink, R. J. et al. A combinational CRISPR\/Cas9 gene-editing approach can halt HIV replication and prevent viral escape. Sci. Rep. 7, 41968 (2017).","journal-title":"Sci. Rep."},{"key":"17936_CR25","doi-asserted-by":"publisher","first-page":"e1005701","DOI":"10.1371\/journal.ppat.1005701","volume":"12","author":"FR van Diemen","year":"2016","unstructured":"van Diemen, F. R. et al. CRISPR\/Cas9-mediated genome editing of herpesviruses limits productive and latent infections. PLoS Pathog. 12, e1005701 (2016).","journal-title":"PLoS Pathog."},{"key":"17936_CR26","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1089\/hum.2017.151","volume":"29","author":"AM Bradbury","year":"2018","unstructured":"Bradbury, A. M. et al. AAVrh10 gene therapy ameliorates central and peripheral nervous system disease in canine globoid cell leukodystrophy (Krabbe disease). Hum. Gene Ther. 29, 785\u2013801 (2018).","journal-title":"Hum. Gene Ther."},{"key":"17936_CR27","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/nn.4593","volume":"20","author":"KY Chan","year":"2017","unstructured":"Chan, K. Y. et al. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat. Neurosci. 20, 1172\u20131179 (2017).","journal-title":"Nat. Neurosci."},{"key":"17936_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nn.3881","volume":"18","author":"D Usoskin","year":"2015","unstructured":"Usoskin, D. et al. Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing. Nat. Neurosci. 18, 145\u2013153 (2015).","journal-title":"Nat. Neurosci."},{"key":"17936_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/cr.2015.149","volume":"26","author":"CL Li","year":"2016","unstructured":"Li, C. L. et al. Somatosensory neuron types identified by high-coverage single-cell RNA-sequencing and functional heterogeneity. Cell Res. 26, 83\u2013102 (2016).","journal-title":"Cell Res"},{"key":"17936_CR30","doi-asserted-by":"publisher","first-page":"e0185543","DOI":"10.1371\/journal.pone.0185543","volume":"12","author":"MQ Nguyen","year":"2017","unstructured":"Nguyen, M. Q., Wu, Y., Bonilla, L. S., von Buchholtz, L. J. & Ryba, N. J. P. Diversity amongst trigeminal neurons revealed by high throughput single cell sequencing. PLoS One 12, e0185543 (2017).","journal-title":"PLoS One"},{"key":"17936_CR31","doi-asserted-by":"publisher","first-page":"8157","DOI":"10.1128\/JVI.00474-07","volume":"81","author":"Y Hoshino","year":"2007","unstructured":"Hoshino, Y., Pesnicak, L., Cohen, J. I. & Straus, S. E. Rates of reactivation of latent herpes simplex virus from mouse trigeminal ganglia ex vivo correlate directly with viral load and inversely with number of infiltrating CD8+ T cells. J. Virol. 81, 8157\u20138164 (2007).","journal-title":"J. Virol."},{"key":"17936_CR32","doi-asserted-by":"publisher","first-page":"6888","DOI":"10.1128\/JVI.72.8.6888-6892.1998","volume":"72","author":"NM Sawtell","year":"1998","unstructured":"Sawtell, N. M. The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia. J. Virol. 72, 6888\u20136892 (1998).","journal-title":"J. Virol."},{"key":"17936_CR33","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.1128\/JVI.72.7.5343-5350.1998","volume":"72","author":"NM Sawtell","year":"1998","unstructured":"Sawtell, N. M., Poon, D. K., Tansky, C. S. & Thompson, R. L. The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation. J. Virol. 72, 5343\u20135350 (1998).","journal-title":"J. Virol."},{"key":"17936_CR34","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.virol.2009.02.004","volume":"387","author":"Y Hoshino","year":"2009","unstructured":"Hoshino, Y., Pesnicak, L., Straus, S. E. & Cohen, J. I. Impairment in reactivation of a latency associated transcript (LAT)-deficient HSV-2 is not solely dependent on the latent viral load or the number of CD8(+) T cells infiltrating the ganglia. Virology 387, 193\u2013199 (2009).","journal-title":"Virology"},{"key":"17936_CR35","doi-asserted-by":"publisher","first-page":"20140160","DOI":"10.1098\/rsif.2014.0160","volume":"11","author":"JT Schiffer","year":"2014","unstructured":"Schiffer, J. T., Mayer, B. T., Fong, Y., Swan, D. A. & Wald, A. Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding. J. R. Soc. Interface 11, 20140160 (2014).","journal-title":"J. R. Soc. Interface"},{"key":"17936_CR36","doi-asserted-by":"publisher","unstructured":"Oh, H. S. et al. Herpesviral lytic gene functions render the viral genome susceptible to novel editing by CRISPR\/Cas9. Elife https:\/\/doi.org\/10.7554\/eLife.51662 (2019).","DOI":"10.7554\/eLife.51662"},{"key":"17936_CR37","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/mt.2008.171","volume":"16","author":"DM McCarty","year":"2008","unstructured":"McCarty, D. M. & Self-complementary, A. A. V. vectors; advances and applications. Mol. Ther. 16, 1648\u20131656 (2008).","journal-title":"Mol. Ther."},{"key":"17936_CR38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.virol.2015.02.009","volume":"479-480","author":"DM Knipe","year":"2015","unstructured":"Knipe, D. M. Nuclear sensing of viral DNA, epigenetic regulation of herpes simplex virus infection, and innate immunity. Virology 479-480, 153\u2013159 (2015).","journal-title":"Virology"},{"key":"17936_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10366-y","volume":"10","author":"PK Dash","year":"2019","unstructured":"Dash, P. K. et al. Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice. Nat. Commun. 10, 2753 (2019).","journal-title":"Nat. Commun."},{"key":"17936_CR40","unstructured":"Stone, D. et al. CRISPR\/Cas9 gene editing of hepatitis B virus promotes hepatocyte survival in chronically infected humanized mice. Molecular Therapy. 2020. In review."},{"key":"17936_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-018-0544-1","volume":"16","author":"P Roychoudhury","year":"2018","unstructured":"Roychoudhury, P. et al. Viral diversity is an obligate consideration in CRISPR\/Cas9 designs for targeting the HIV reservoir. BMC Biol. 16, 75 (2018).","journal-title":"BMC Biol."},{"key":"17936_CR42","doi-asserted-by":"publisher","first-page":"8920","DOI":"10.1128\/JVI.00052-12","volume":"86","author":"JT Schiffer","year":"2012","unstructured":"Schiffer, J. T. et al. Targeted DNA mutagenesis for the cure of chronic viral infections. J. Virol. 86, 8920\u20138936 (2012).","journal-title":"J. Virol."},{"key":"17936_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","volume":"36","author":"FL Graham","year":"1977","unstructured":"Graham, F. L., Smiley, J., Russell, W. C. & Nairn, R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59\u201374 (1977).","journal-title":"J. Gen. Virol."},{"key":"17936_CR44","first-page":"Unit 16.25","volume":"Chapter 16","author":"VW Choi","year":"2007","unstructured":"Choi, V. W., Asokan, A., Haberman, R. A. & Samulski, R. J. Production of recombinant adeno-associated viral vectors for in vitro and in vivo use. Curr. Protoc. Mol. Biol. Chapter 16, Unit 16.25 (2007).","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"17936_CR45","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/sj.gt.3300938","volume":"6","author":"S Zolotukhin","year":"1999","unstructured":"Zolotukhin, S. et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6, 973\u2013985 (1999).","journal-title":"Gene Ther."},{"key":"17936_CR46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1089\/hgtb.2011.034","volume":"23","author":"C Aurnhammer","year":"2012","unstructured":"Aurnhammer, C. et al. Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences. Hum. Gene Ther. Methods 23, 18\u201328 (2012).","journal-title":"Hum. Gene Ther. Methods"},{"key":"17936_CR47","doi-asserted-by":"publisher","first-page":"6669","DOI":"10.1128\/JVI.00204-11","volume":"85","author":"AS Bertke","year":"2011","unstructured":"Bertke, A. S. et al. A5-positive primary sensory neurons are nonpermissive for productive infection with herpes simplex virus 1 in vitro. J. Virol. 85, 6669\u20136677 (2011).","journal-title":"J. Virol."},{"key":"17936_CR48","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/nprot.2006.461","volume":"2","author":"SA Malin","year":"2007","unstructured":"Malin, S. A., Davis, B. M. & Molliver, D. C. Production of dissociated sensory neuron cultures and considerations for their use in studying neuronal function and plasticity. Nat. Protoc. 2, 152\u2013160 (2007).","journal-title":"Nat. Protoc."},{"key":"17936_CR49","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"17936_CR50","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17936-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17936-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17936-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T14:12:20Z","timestamp":1722953540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17936-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,18]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["17936"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-17936-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,18]]},"assertion":[{"value":"26 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.G. and P.D. are employees of Cellectis SA. All the other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4148"}}